Tower Research Capital (TRC)’s Counterpath Corp CPAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-100
| Closed | – | – | 6065 |
|
|
2020
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 5660 |
|
|
2020
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 5368 |
|
|
2020
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 5200 |
|
|
2020
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 4469 |
|
|
2019
Q4 | $0 | Hold |
100
| – | – | ﹤0.01% | 4902 |
|
|
2019
Q3 | $0 | Hold |
100
| – | – | ﹤0.01% | 4860 |
|
|
2019
Q2 | $0 | Hold |
100
| – | – | ﹤0.01% | 4745 |
|
|
2019
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 4731 |
|
|
2018
Q4 | $0 | Sell |
100
-400
| -80% | -$767 | ﹤0.01% | 4789 |
|
|
2018
Q3 | $1K | Buy |
500
+200
| +67% | +$457 | ﹤0.01% | 3693 |
|
|
2018
Q2 | $1K | Sell |
300
-200
| -40% | -$512 | ﹤0.01% | 3574 |
|
|
2018
Q1 | $1K | Buy |
500
+300
| +150% | +$1.18K | ﹤0.01% | 3161 |
|
|
2017
Q4 | $1K | Buy |
200
+195
| +3,900% | +$502 | ﹤0.01% | 3432 |
|
|
2017
Q3 | $0 | Sell |
5
-295
| -98% | -$764 | ﹤0.01% | 4464 |
|
|
2017
Q2 | $1K | Buy |
300
+200
| +200% | +$418 | ﹤0.01% | 2604 |
|
|
2017
Q1 | $0 | Sell |
100
-500
| -83% | -$1.23K | ﹤0.01% | 4594 |
|
|
2016
Q4 | $1K | Sell |
600
-300
| -33% | -$620 | ﹤0.01% | 3747 |
|
|
2016
Q3 | $2K | Sell |
900
-200
| -18% | -$440 | ﹤0.01% | 3232 |
|
|
2016
Q2 | $2K | Buy |
1,100
+300
| +38% | +$675 | ﹤0.01% | 4082 |
|
|
2016
Q1 | $2K | Buy |
800
+7
| +0.9% | +$16 | ﹤0.01% | 3581 |
|
|
2015
Q4 | $2K | Buy |
+793
| New | +$2.67K | ﹤0.01% | 3964 |
|
|
2014
Q1 | – | Sell |
-53
| Closed | -$1K | – | 5362 |
|
|
2013
Q4 | $1K | Sell |
53
-89
| -63% | -$1.17K | ﹤0.01% | 4345 |
|
|
2013
Q3 | $2K | Buy |
142
+134
| +1,675% | +$2.19K | ﹤0.01% | 4211 |
|
|
2013
Q2 | $0 | Buy |
+8
| New | +$145 | ﹤0.01% | 4035 |
|
Tower Research Capital (TRC)'s CPAH Position: Q1 2021 in Review
Tower Research Capital (TRC) sold out of Counterpath Corp (CPAH) in Q1 2021, closing a stake of 100 shares.
Tower Research Capital (TRC) first reported a position in CPAH in Q2 2013 and held it in 24 quarters. The position peaked at $2K in Q3 2016. 0 funds tracked by Wall St. Rank hold CPAH as of Q1 2021.
- Tower Research Capital (TRC) reported no remaining Counterpath Corp position as of Q1 2021 after selling out during the quarter.
- Tower Research Capital (TRC) sold 100 Counterpath Corp shares in Q1 2021.
- Tower Research Capital (TRC) first reported a position in Counterpath Corp in Q2 2013 and held it in 24 quarters.
- Tower Research Capital (TRC)'s Counterpath Corp position peaked at $2K in Q3 2016.
- 0 funds tracked by Wall St. Rank held Counterpath Corp as of Q1 2021.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2021, filed 17 May 2021.